ASCO 2016

03–07 June 2016 | McCormick Place, Chicago, IL, United States
American Society Of Clinical Oncology (ASCO) 2016 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on Jun 3 -7, 2016 at McCormick Place.

ASCO 2016

03–07 June 2016 | McCormick Place, Chicago, IL, United States
American Society Of Clinical Oncology (ASCO) 2016 Annual Meeting is organized by American Society Of Clinical Oncology (ASCO) and was held on Jun 3 -7, 2016 at McCormick Place.
Genomic testing: a precision-medicine approach applied to early-stage prostate cancer 2:26
Genomic testing: a precision-medicine approach applied to early-stage prostate cancer
Eric Klein • 5 Jun 2016
The impact of preoperative malnutrition on surgery outcome in cancer patients 2:41
The impact of preoperative malnutrition on surgery outcome in cancer patients
Jalid Sehouli • 3 Jun 2016
Results of TRIAS 2009 trial of sorafenib with topotecan in ovarian cancer 1:38
Results of TRIAS 2009 trial of sorafenib with topotecan in ovarian cancer
Jalid Sehouli • 3 Jun 2016
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign 4:25
Aggressive care at the end-of-life for younger cancer patients: ASCO’s Choosing Wisely campaign
Ronald Chen • 3 Jun 2016
Disparities in cancer risk management among BRCA carriers 5:49
Disparities in cancer risk management among BRCA carriers
Tuya Pal • 3 Jun 2016
Global differences in cancer drug prices: a comparative analysis 4:28
Global differences in cancer drug prices: a comparative analysis
Daniel Goldstein • 3 Jun 2016
Improved overall survival in lung cancer patients using Moovcare compared to standard modalities 2:58
Improved overall survival in lung cancer patients using Moovcare compared to standard modalities
Fabrice Denis • 3 Jun 2016
Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC) 7:14
Safety and efficacy of single agent rovalpituzumab tesirine in small cell lung cancer (SCLC)
Charles Rudin • 3 Jun 2016
FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma 8:41
FAST: a Phase III trial of an anti-CLDN18.2 antibody GEJ adenocarcinoma
Salah-Eddin Al-Batran • 3 Jun 2016
The metastatic breast cancer project: accelerating genomics research 5:32
The metastatic breast cancer project: accelerating genomics research
Nikhil Wagle • 3 Jun 2016
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway 6:11
Targeted therapy for advanced solid tumors based on molecular profiles: early results from MyPathway
John Hainsworth • 3 Jun 2016
Developments in PD-1 and PD-L1 inhibitors presented at ASCO 2016 2:10
Developments in PD-1 and PD-L1 inhibitors presented at ASCO 2016
Justin Stebbing • 3 Jun 2016
Subgrouping rarer cancers and clinical trial design 1:18
Subgrouping rarer cancers and clinical trial design
Bruce Johnson • 5 Jun 2016
How do we deal with rising drug costs? 1:39
How do we deal with rising drug costs?
Bruce Johnson • 5 Jun 2016
The challenges Prof. Bruce Johnson will face as President-elect of ASCO 0:58
The challenges Prof. Bruce Johnson will face as President-elect of ASCO
Bruce Johnson • 5 Jun 2016
Precision medicine: from academic centers to community practices 0:56
Precision medicine: from academic centers to community practices
Bruce Johnson • 5 Jun 2016

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals